Boston Partners Has $315,000 Stake in The Joint Corp. (NASDAQ:JYNT)

Boston Partners cut its stake in The Joint Corp. (NASDAQ:JYNT) by 35.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 29,613 shares of the company’s stock after selling 16,545 shares during the quarter. Boston Partners’ holdings in Joint were worth $315,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of JYNT. Douglass Winthrop Advisors LLC raised its position in Joint by 4.1% in the 3rd quarter. Douglass Winthrop Advisors LLC now owns 146,400 shares of the company’s stock valued at $1,675,000 after buying an additional 5,800 shares during the last quarter. FMR LLC grew its position in Joint by 38.0% in the 3rd quarter. FMR LLC now owns 10,787 shares of the company’s stock worth $123,000 after purchasing an additional 2,971 shares in the last quarter. BNP Paribas Financial Markets increased its stake in Joint by 5.4% in the 3rd quarter. BNP Paribas Financial Markets now owns 22,510 shares of the company’s stock valued at $258,000 after buying an additional 1,156 shares during the last quarter. O Brien Greene & Co. Inc lifted its position in shares of Joint by 3.5% during the 3rd quarter. O Brien Greene & Co. Inc now owns 119,620 shares of the company’s stock worth $1,368,000 after buying an additional 4,000 shares in the last quarter. Finally, Barclays PLC boosted its stake in shares of Joint by 71.4% in the 3rd quarter. Barclays PLC now owns 25,609 shares of the company’s stock worth $294,000 after buying an additional 10,671 shares during the last quarter. Institutional investors own 76.88% of the company’s stock.

Joint Stock Performance

NASDAQ JYNT opened at $12.73 on Monday. The company has a market capitalization of $193.18 million, a PE ratio of -11.17 and a beta of 1.61. The Joint Corp. has a 52-week low of $9.58 and a 52-week high of $17.82. The company has a 50-day simple moving average of $11.26 and a 200 day simple moving average of $11.18.

Analysts Set New Price Targets

Separately, StockNews.com lowered Joint from a “buy” rating to a “hold” rating in a report on Monday, March 17th.

Joint Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.